MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-17-0011153
Maxwell Life Science Limited - chemicals in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹136.55 Cr
▲ 67% YoY
Net profit · FY 2025
₹8.99 Cr
Net margin 6.6%
EBITDA · FY 2025
₹15.32 Cr
EBITDA margin 11.2%
Authorised capital
₹22.3 Cr
Registered with MCA
Paid-up capital
₹15.79 Cr
Issued & subscribed
Open charges
₹21.37 Cr
Satisfied ₹14.61 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
22
Provident fund records
About Maxwell Life Science Limited
Data last updated:
Maxwell Life Science Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 25 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PLC146536. Its GSTIN is 27AAECM0706E1ZX (Maharashtra).
The company has an authorised share capital of ₹22.3 Cr and a paid-up capital of ₹15.79 Cr. It is led by directors including Sanjay Bastimal Surana (Managing Director) and Neetu Sanjay Surana (Whole-Time Director).
Its last annual general meeting (AGM) was held on 21 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹136.55 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹8.99 Cr (net margin 6.6%) and EBITDA of ₹15.32 Cr (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years and 37% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Maxwell Life Science Limited. As per MCA filings, the company has open charges of ₹21.37 Cr and satisfied charges of ₹14.61 Cr on record. Court records list 13 cases involving the company, including 2 filed by the company and 11 filed against it; 5 cases are pending.
Maxwell Life Science Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-17-0011153). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mlspl.in.
Company Details of Maxwell Life Science Limited
CIN U24230MH2004PLC146536
Registration Number 146536
Incorporation Date 25 May 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 21 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-17-0011153
CIN History of Maxwell Life Science Limited
Maxwell Life Science has one previous CIN (Corporate Identification Number): U24230MH2004PTC146536. The current CIN is U24230MH2004PLC146536, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2004PLC146536 | Current |
| U24230MH2004PTC146536 | Previous |
Key People
Sanjay Bastimal Surana Managing Director Neetu Sanjay Surana Whole-Time Director Rajendra Runwal Director Recognitions & Rankings of Maxwell Life Science
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressOffice No. 401 402 & 403 4th Floor, Target Mall Chandavarkar Road, Mumbai, Maharashtra, India – 400092
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Maxwell Life Science Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Maxwell Life Science Limited
Maxwell Life Science operates one associated brand: Maxwell Life Science Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical formulations. | mlspl.in |
Business Activity of Maxwell Life Science Limited
The main business activity of Maxwell Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maxwell Life Science Limited FY 2024 filings available
Maxwell Life Science Limited reported revenue of ₹136.55 Cr (up 67% YoY) for FY 2025.
Revenue · FY 2025
₹136.55 Cr ▲ 67%
Net profit · FY 2025
₹8.99 Cr margin 6.6%
EBITDA · FY 2025
₹15.32 Cr margin 11.2%
Compounded Annual Growth Rate (CAGR) of Maxwell Life Science Limited
Revenue CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 67%
5 years · compounded
▲ 37%
EBITDA CAGR growth
1 year
▲ 62%
3 years · compounded
▲ 71%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 67% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maxwell Life Science Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.32 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.99 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maxwell Life Science Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxwell Life Science are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Maxwell Life Science Limited
Maxwell Life Science has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Bastimal Surana Also directs: Victo Nutras LLP | Managing Director | 25 May 2004 | 22 Years 4 Months | Current |
| Rajendra Runwal | Director | 18 Mar 2024 | 2 Years 7 Months | Current |
| Vijay Kumar Sagarmal Singhavi | Director | 18 Mar 2024 | 2 Years 7 Months | Current |
| Neetu Sanjay Surana Also directs: Victo Nutras LLP | Whole-Time Director | 30 Mar 2015 | 11 Years 6 Months | Current |
| Nayankant Hasmukhlal Gadoya | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
Peer Comparison of Maxwell Life Science Limited
Maxwell Life Science Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ontop Pharmaceuticals Private Limited | ₹138.93 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Hosur Road, Bangalore, Karnataka, India |
| Sundyota Numandis Probioceuticals Private Limited | ₹138.84 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Ahmedabad, Gujarat, India |
| Jay Formulations Ltd | ₹138.71 Cr (FY 2021) | •••• | •••• | 11.0% | •••• | Ahmedabad, Gujarat, India |
| M.M. Remedies Private Limited | ₹137.33 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Llucknow, Uttar Pradesh, India |
| Palsons Derma Private Limited | ₹137.11 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Maxwell Life Science Limited this company | ₹136.55 Cr (FY 2025) | •••• | •••• | 67.0% | •••• | Mumbai, Maharashtra, India |
| Lewens Labs Private Limited | ₹136.52 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Bharuch, Gujarat, India |
| Naari Pharma Private Limited | ₹136.35 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Bangalore, Karnataka, India |
| Zenith Drugs Limited | ₹135.93 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Indore, Madhya Pradesh, India |
| Alpa Laboratories Limited Listed | ₹135.8 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Indore, Madhya Pradesh, India |
| Ravoo's Laboratories Limited | ₹134.97 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Maxwell Life Science by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Maxwell Life Science Limited
Maxwell Life Science Limited is audited by JPJ ASSOCIATES LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JPJ ASSOCIATES LLP | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Maxwell Life Science Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxwell Life Science Limited
Open charges
₹21.37 Cr
Satisfied charges
₹14.61 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2025 | Others | ₹1.32 Cr | Open |
| 04 Sep 2025 | Others | ₹31.5 Lakh | Open |
| 23 May 2025 | Others | ₹3 Cr | Open |
| 01 Nov 2023 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹70 Lakh | Open |
| 31 Jan 2023 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹1.25 Cr | Open |
Total charge records: 15 View all charges
Legal Cases of Maxwell Life Science Limited
Maxwell Life Science Limited has 13 court cases on record: 2 filed by Maxwell Life Science, 11 filed against it. 5 cases are pending and 8 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Total cases
13
Filed by the company
2
Filed against the company
11
Pending
5
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 6 | 4 |
| District courts | 6 | 5 | 1 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CRR) | Filed against the company by Socomed Pharma Private Limited | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by Tagoor Laboratories Private Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Socomed Pharma Private Limited | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Socomed Pharma Private Limited | Disposed |
| District court, Vadodara, Gujarat | Commercial matter | Filed against the company by Comed Chemicals Limited | Disposed |
Premium access
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Maxwell Life Science Limited
Maxwell Life Science Limited has a workforce of 22 employees as of Feb 27, 2025.
Employee count
22
Active EPFO establishments
1
Employee growth
4.76%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxwell Life Science Limited
Maxwell Life Science Limited has 14 board changes on record since 2004: 5 appointments and 9 cessations. The latest: Nayankant Hasmukhlal Gadoya ceased to be Additional Director on 01 Apr 2025.
Charges
A charge with Others amounted to Rs. 1.32 Cr with Charge ID 101151404 was registered on 04 Sep 2025.
Charges
A charge with Others amounted to Rs. 0.32 Cr with Charge ID 101151400 was registered on 04 Sep 2025.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101099026 was registered on 23 May 2025.
Ceased
Nayankant Hasmukhlal Gadoya ceased to be Additional Director.
Appointed
Nayankant Hasmukhlal Gadoya was appointed as Director.
Ceased
Piyush Narayan Trivedi ceased to be Director.
Charges
A charge with Others of Rs. 14.00 Cr registered on 11 Dec 2009 with Charge ID 10192165 was modified on 09 Dec 2024.
AGM
Maxwell Life Science Limited last Annual general meeting of members was held on 21 Sep 2024 as per latest MCA records.
Filing
Maxwell Life Science Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Rajendra Runwal was appointed as Director.
Appointed
Vijay Kumar Sagarmal Singhavi was appointed as Director.
Ceased
Sanjay Bastimal Surana ceased to be Director.
33 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Maxwell Life Science Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxwell Life Science Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxwell Life Science Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxwell Life Science Limited
Maxwell Life Science has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECM0706E1ZX | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxwell Life Science Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxwell Life Science Limited
Maxwell Life Science is an active public limited company based in Mumbai, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 25 May 2004 (22+ years old) and is registered under CIN U24230MH2004PLC146536.
Maxwell Life Science reported revenue of ₹136.55 Cr for FY 2025 (up 67% YoY).
Maxwell Life Science has 5 current directors:
- Sanjay Bastimal Surana - Managing Director
- Neetu Sanjay Surana - Whole-Time Director
- Rajendra Runwal - Director
- Vijay Kumar Sagarmal Singhavi - Director
- Nayankant Hasmukhlal Gadoya - Director
Maxwell Life Science reported a net profit of ₹8.99 Cr (net margin 6.6%) and EBITDA of ₹15.32 Cr (EBITDA margin 11.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maxwell Life Science is 67% over three years and 37% over five years. In the latest year (FY 2025) revenue rose 67%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maxwell Life Science is 27AAECM0706E1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Maxwell Life Science is U24230MH2004PLC146536. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxwell Life Science has 13 court cases on record: 2 filed by the company and 11 filed against it. 5 are pending. Most are in the high courts.
Maxwell Life Science was incorporated on 25 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Maxwell Life Science by revenue are Ontop Pharmaceuticals Private Limited, Sundyota Numandis Probioceuticals Private Limited, Jay Formulations Ltd, M.M. Remedies Private Limited, Palsons Derma Private Limited and 5 more, all in the Pharma industry (Formulations).
Nayankant Hasmukhlal Gadoya ceased to be Additional Director on 01 Apr 2025. Nayankant Hasmukhlal Gadoya was appointed as Director on 20 Mar 2025. Piyush Narayan Trivedi ceased to be Director on 11 Mar 2025. Maxwell Life Science has 14 board changes on record in total.